M
Maria João Silva
Researcher at Universidade Nova de Lisboa
Publications - 171
Citations - 2492
Maria João Silva is an academic researcher from Universidade Nova de Lisboa. The author has contributed to research in topics: Medicine & Genotoxicity. The author has an hindex of 23, co-authored 143 publications receiving 1796 citations. Previous affiliations of Maria João Silva include Polytechnic Institute of Porto & Instituto Superior de Agronomia.
Papers
More filters
Journal ArticleDOI
Intra- and inter-laboratory variation in the scoring of micronuclei and nucleoplasmic bridges in binucleated human lymphocytes. Results of an international slide-scoring exercise by the HUMN project
Michael Fenech,Stefano Bonassi,Julie Turner,Cecilia Lando,Marcello Ceppi,Wushou P. Chang,Nina Holland,Micheline Kirsch-Volders,Errol Zeiger,Maria Paola Bigatti,Claudia Bolognesi,Jia Cao,Giuseppe De Luca,Marina Di Giorgio,Lynnette R. Ferguson,Aleksandra Fučić,Omar Garcia Lima,Valeria Hadjidekova,Patrizia Hrelia,Alicja Jaworska,Gordana Joksić,A. P. Krishnaja,Tung Kwang Lee,Antonietta Martelli,Michael J. McKay,Lucia Migliore,Ekaterina Mirkova,Wolfgang-Ulrich Müller,Youichi Odagiri,Thierry Orsière,Maria Rosaria Scarfì,Maria João Silva,Toshio Sofuni,Jordi Suralles,Giorgio Trenta,Irena Vorobtsova,Anne Vral,Andrea Zijno +37 more
TL;DR: In this article, an inter-laboratory slide-scoring exercise was performed among 34 laboratories from 21 countries with a total of 51 slide scorers involved, and the results of these studies indicate clearly that even after standardizing culture and scoring conditions it will be necessary to calibrate scorers and laboratories if MN, MNed cell and nucleoplasmic bridge frequencies are reliably compared among laboratories and among populations.
Journal ArticleDOI
High throughput toxicity screening and intracellular detection of nanomaterials
Andrew Collins,Balasubramanyam Annangi,Laura Rubio,Ricard Marcos,Marco Dorn,Carolin Merker,Irina Estrela-Lopis,Mihaela Roxana Cimpan,Mohamed I. M. Ibrahim,Emil Cimpan,Melanie Ostermann,Alexander Sauter,Naouale El Yamani,Sergey Shaposhnikov,Sylvie Chevillard,Vincent Paget,Romain Grall,Jozo Delic,Felipe Goñi de-Cerio,Blanca Suarez-Merino,Valérie Fessard,Kevin Hogeveen,Lise Maria Fjellsbø,Elise Runden Pran,Tana Brzicova,Jan Topinka,Maria João Silva,Paulo Emílio Corrêa Leite,Ana R. Ribeiro,José Mauro Granjeiro,Roland C. Grafström,Adriele Prina-Mello,Maria Dusinska +32 more
TL;DR: Several HTS/HCA methods are being validated and applied for NM testing in the FP7 project NANoREG, including Label‐free cellular screening of NM uptake, HTS, HCA, High throughput flow cytometry, Impedance‐based monitoring, Multiplex analysis of secreted products, and genotoxicity methods.
Journal ArticleDOI
Towards a nanospecific approach for risk assessment.
Susan Dekkers,Agnes G. Oomen,Eric A.J. Bleeker,Rob J. Vandebriel,Christian Micheletti,Joan Cabellos,Gemma Janer,Natalia Fuentes,Socorro Vázquez-Campos,T. Borges,Maria João Silva,Adriele Prina-Mello,Dania Movia,Fabrice Nesslany,Ana R. Ribeiro,Paulo Emílio Corrêa Leite,Monique Groenewold,Flemming R. Cassee,Adriënne J.A.M. Sips,Aart Dijkzeul,Tom van Teunenbroek,Susan Wijnhoven +21 more
TL;DR: In the proposed risk assessment strategy, approaches for (Quantitative) Structure Activity Relationships, grouping and read-across are integrated and expanded to guide the user how to prioritise those nanomaterial applications that may lead to high risks for human health.
Journal ArticleDOI
Genotoxicity evaluation of nanosized titanium dioxide, synthetic amorphous silica and multi-walled carbon nanotubes in human lymphocytes.
Ana Tavares,Henriqueta Louro,Susana Antunes,Stephanie Quarré,Sophie Simar,Pieter-Jan De Temmerman,Eveline Verleysen,Jan Mast,Keld Alstrup Jensen,Hannu Norppa,Fabrice Nesslany,Maria João Silva +11 more
TL;DR: The differential genotoxicity observed for closely related NMs highlights the importance of investigating the toxic potential of each NM individually, instead of assuming a common mechanism and equal genotoxic effects for a set of similar NMs.
Journal ArticleDOI
Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future.
Henriqueta Louro,Milla Heinälä,Jos Bessems,Jurgen Buekers,Theo Vermeire,Marjolijn Woutersen,Jacqueline van Engelen,T. Borges,Christophe Rousselle,Eva Ougier,Paula Alvito,Carla Martins,Ricardo Assunção,Maria João Silva,Anjoeka Pronk,Bernice Schaddelee-Scholten,Maria Del Carmen Gonzalez,Mercedes de Alba,Argelia Castaño,Susana Viegas,Tatjana Humar-Juric,Lijana Kononenko,Alfonso Lampen,Anne Marie Vinggaard,Greet Schoeters,Marike Kolossa-Gehring,Tiina Santonen +26 more
TL;DR: The state-of-the-art of HBM use in chemicals RA with a special focus in Europe is reviewed, the availability of guidance on how to use it in RA is analyzed, and attempts to identify hurdles and challenges faced by regulators are identified.